ES3036094T3 - 2-fluorinated bile acids for the treatment of neurodegenerative diseases - Google Patents

2-fluorinated bile acids for the treatment of neurodegenerative diseases

Info

Publication number
ES3036094T3
ES3036094T3 ES19831850T ES19831850T ES3036094T3 ES 3036094 T3 ES3036094 T3 ES 3036094T3 ES 19831850 T ES19831850 T ES 19831850T ES 19831850 T ES19831850 T ES 19831850T ES 3036094 T3 ES3036094 T3 ES 3036094T3
Authority
ES
Spain
Prior art keywords
compound
general formula
dihydroxy
difluoro
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19831850T
Other languages
English (en)
Spanish (es)
Inventor
Alexander Weymouth-Wilson
Bruno Jan Pol Linclau
Gemma Packer
Joseph WATTS
Heather Mortiboys
Oliver Bandmann
Christopher Hastings
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southampton
Nzp Uk Ltd
Original Assignee
University of Southampton
Nzp Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southampton, Nzp Uk Ltd filed Critical University of Southampton
Application granted granted Critical
Publication of ES3036094T3 publication Critical patent/ES3036094T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES19831850T 2018-12-20 2019-12-20 2-fluorinated bile acids for the treatment of neurodegenerative diseases Active ES3036094T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1820887.6A GB201820887D0 (en) 2018-12-20 2018-12-20 Compounds
PCT/GB2019/053665 WO2020128514A1 (en) 2018-12-20 2019-12-20 2-fluorinated bile acids for the treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
ES3036094T3 true ES3036094T3 (en) 2025-09-12

Family

ID=65364420

Family Applications (1)

Application Number Title Priority Date Filing Date
ES19831850T Active ES3036094T3 (en) 2018-12-20 2019-12-20 2-fluorinated bile acids for the treatment of neurodegenerative diseases

Country Status (15)

Country Link
US (1) US20220073557A1 (cg-RX-API-DMAC7.html)
EP (1) EP3898645B1 (cg-RX-API-DMAC7.html)
JP (1) JP7503063B2 (cg-RX-API-DMAC7.html)
KR (1) KR102856276B1 (cg-RX-API-DMAC7.html)
CN (1) CN113330020B (cg-RX-API-DMAC7.html)
AU (1) AU2019411556B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021011189A2 (cg-RX-API-DMAC7.html)
CA (1) CA3123333A1 (cg-RX-API-DMAC7.html)
EA (1) EA202191521A1 (cg-RX-API-DMAC7.html)
ES (1) ES3036094T3 (cg-RX-API-DMAC7.html)
GB (1) GB201820887D0 (cg-RX-API-DMAC7.html)
IL (1) IL284093B2 (cg-RX-API-DMAC7.html)
MX (1) MX2021007551A (cg-RX-API-DMAC7.html)
SG (1) SG11202105465WA (cg-RX-API-DMAC7.html)
WO (1) WO2020128514A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4486318A4 (en) * 2022-03-02 2026-02-25 Boyce Thompson Institute For Plant Res Inc Cysteamides, related therapeutic compositions and associated processes
GB202208151D0 (en) 2022-06-01 2022-07-13 Nzp Uk Ltd Compounds
GB202314563D0 (en) 2023-09-22 2023-11-08 Nzp Uk Ltd Compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9509764A (pt) * 1994-11-23 1998-07-07 Cocensys Inc Série androstano e pregnano para modulação alostérica de receptor de gaba
AU3967297A (en) * 1996-08-01 1998-02-25 Cocensys, Inc. Use of gaba and nmda receptor ligands for the treatment of migraine headache
FR2934596B1 (fr) * 2008-07-30 2015-04-10 Trophos Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation
ITMI20121344A1 (it) * 2012-07-31 2014-02-01 Erregierre Spa Processo di preparazione di acido ursodesossicolico ad elevata purezza
WO2014036379A2 (en) * 2012-08-31 2014-03-06 Metselex Bile acids prevent or abolish progression of parkinson's and related neurodegenerative diseases
CN103333216A (zh) * 2013-06-04 2013-10-02 苏州大学 5α-6-酮-胆甾烷类似物及其应用
US20150112089A1 (en) 2013-10-22 2015-04-23 Metselex, Inc. Deuterated bile acids
CN107531741A (zh) * 2015-03-10 2018-01-02 美莱斯股份有限公司 氟化和烷基化胆酸
GB201812382D0 (en) * 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds

Also Published As

Publication number Publication date
WO2020128514A1 (en) 2020-06-25
EP3898645C0 (en) 2025-06-25
CA3123333A1 (en) 2020-06-25
MX2021007551A (es) 2021-10-13
JP7503063B2 (ja) 2024-06-19
GB201820887D0 (en) 2019-02-06
CN113330020A (zh) 2021-08-31
EP3898645A1 (en) 2021-10-27
AU2019411556A1 (en) 2021-06-10
IL284093B2 (en) 2025-07-01
IL284093B1 (en) 2025-03-01
JP2022514401A (ja) 2022-02-10
BR112021011189A2 (pt) 2021-08-31
KR102856276B1 (ko) 2025-09-05
AU2019411556B2 (en) 2025-04-03
EA202191521A1 (ru) 2021-09-10
US20220073557A1 (en) 2022-03-10
CN113330020B (zh) 2024-04-05
IL284093A (en) 2021-08-31
EP3898645B1 (en) 2025-06-25
KR20210125982A (ko) 2021-10-19
SG11202105465WA (en) 2021-06-29

Similar Documents

Publication Publication Date Title
US20240116952A1 (en) Kras inhibitor and pharmaceutical uses thereof
CA3220847A1 (en) Protease inhibitors as antivirals
JP2016034960A (ja) 1,3−プロパンジスルホン酸を送達するための方法、化合物、および組成物
EA016568B1 (ru) Способы, соединения, композиции и носители для доставки 3-амино-1-пропансульфоновой кислоты
US20170354639A1 (en) Diterpenoid derivatives and methods of use thereof
CN113330020B (zh) 用于治疗神经变性疾病的2-氟代的胆汁酸
KR20190134722A (ko) 치료 화합물 및 방법
CN114805478A (zh) 氘代拟肽类化合物及其用途
CN121511234A (zh) 用于rna递送的可电离阳离子脂质
US20250320246A1 (en) 3-azasteroid compounds for the treatment of diseases related to mitrochondrial function
CN116514902A (zh) 氘代拟肽类化合物及其用途
CN112218878A (zh) Ntcp抑制剂
US20250011292A1 (en) Novel rhodanine derivatives and uses thereof
US20250034194A1 (en) Inhibitors of abnormal phosphorylation and tau protein aggregation
EA046372B1 (ru) 2-фторированные желчные кислоты для лечения нейродегенеративных заболеваний
HK40062202A (en) 2-fluorinated bile acids for the treatment of neurodegenerative diseases
HK40062202B (en) 2-fluorinated bile acids for the treatment of neurodegenerative diseases
CA3050119A1 (en) Cysteamine prodrugs
ES2200334T3 (es) Estra-5(10),7-dieno con actividad estrogenica.
US20240374617A1 (en) Methods of activating microglial cells
WO2023077977A1 (zh) 秋水仙碱衍生物的制备方法及其用途
ITMI950804A1 (it) Composti lattonici utili per il trattamento dell'osteoporosi
HK1246718A1 (zh) 用於治疗囊性纤维化的化合物